Concert Pharmaceuticals Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Concert Pharma (CNCE) Prices 3.3M Common Stock Offering at $15.15/Share
March 19, 2015 9:24 AM EDTConcert Pharma (NASDAQ: CNCE) announced the pricing of an underwritten public offering of 3,300,000 shares of its common stock at a public offering price of $15.15 per share.
All shares in the offering are being sold by Concert, with expected net proceeds to Concert of approximately $46.7... More
Concert Pharma (CNCE) Plans Common Stock Offering
March 18, 2015 4:28 PM EDTConcert Pharma (NASDAQ: CNCE) announced that it has commenced an underwritten public offering of its common stock. All of the shares in the offering are to be sold by Concert.
Wells Fargo and JMP Securities are acting as joint book-running managers for the... More
